MedPath

Post-Traumatic Knee Osteoarthritis Following Anterior Cruciate Ligament Reconstruction

Recruiting
Conditions
Anterior Cruciate Ligament Injuries
Post-Traumatic Osteoarthritis of Knee
Interventions
Other: Imaging - magnetic resonance imaging (MRI)
Other: Blood sampling
Other: Assessment of functionality and strength
Other: Activity monitoring
Other: Imaging - x-ray scan (RX)
Behavioral: Questionnaires
Registration Number
NCT06201442
Lead Sponsor
Universitaire Ziekenhuizen KU Leuven
Brief Summary

The purpose of this trial is to define knee joint pathomechanics (KJPM) in the first 2 years after ACL reconstruction (ACLR) and relate these KJPM with changes in articular cartilage morphology and quality.

Detailed Description

This research project is a longitudinal prospective study. The investigators aim to define the KJPM longitudinally in the first 2 years following ACLR. The investigators relate these KJPM, combined with the cumulative mechanical exposure, to changes in articular cartilage/joint surface morphology and quality. To investigate the loading pattern on the knee joint, daily activities like walking, running and climbing stairs will be performed by the participants.

The overall goal of this research project is to investigate whether KJPM are related with early cartilage degeneration. This is a first major step towards reducing the risk for post-ACLR onset of Post-Traumatic Knee Osteoarthritis (PTOA).

Two work packages (WP) can be separated, that each have a separate aim:

WP1: The first aim of this WP (WP1.A) is to profile longitudinal changes in knee contact forces (KCFs) and knee contact pressure (KCP) distribution of the articular cartilage in the first 2 years following ACLR. Second, in WP1.B, the investigators will identify multivariate proxies of KCFs (and KCP) to improve clinical translation (for example by facilitating the development of prognostic tools for verifying KJPM in real life).

WP2: the second aim is to establish the relationship between KJPM at different time points following ACLR and (changes in) articular cartilage morphology and quality (WP2.A). Furthermore, the investigators will compare the biomechanical profile of "fast PTOA progressors" with "fast non-traumatic early osteoarthritis progressors" (WP2.B).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Patients undergoing unilateral Anterior Cruciate Ligament Reconstruction (ACLR)Imaging - magnetic resonance imaging (MRI)4 - 5 visits: Clinical examination, magnetic resonance imaging (MRI), 3D motion analysis, Strength assessment, EOS radiography (full leg X-ray scan), X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Healthy controls without previous Anterior Cruciate Ligament (ACL) injuryBlood sampling2 visits: Clinical examination, MRI, 3D motion analysis, Strength assessment, EOS radiography, X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Patients undergoing unilateral Anterior Cruciate Ligament Reconstruction (ACLR)Imaging - x-ray scan (RX)4 - 5 visits: Clinical examination, magnetic resonance imaging (MRI), 3D motion analysis, Strength assessment, EOS radiography (full leg X-ray scan), X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Healthy controls without previous Anterior Cruciate Ligament (ACL) injuryImaging - magnetic resonance imaging (MRI)2 visits: Clinical examination, MRI, 3D motion analysis, Strength assessment, EOS radiography, X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Healthy controls without previous Anterior Cruciate Ligament (ACL) injuryAssessment of functionality and strength2 visits: Clinical examination, MRI, 3D motion analysis, Strength assessment, EOS radiography, X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Healthy controls without previous Anterior Cruciate Ligament (ACL) injuryImaging - x-ray scan (RX)2 visits: Clinical examination, MRI, 3D motion analysis, Strength assessment, EOS radiography, X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Patients undergoing unilateral Anterior Cruciate Ligament Reconstruction (ACLR)Blood sampling4 - 5 visits: Clinical examination, magnetic resonance imaging (MRI), 3D motion analysis, Strength assessment, EOS radiography (full leg X-ray scan), X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Patients undergoing unilateral Anterior Cruciate Ligament Reconstruction (ACLR)Assessment of functionality and strength4 - 5 visits: Clinical examination, magnetic resonance imaging (MRI), 3D motion analysis, Strength assessment, EOS radiography (full leg X-ray scan), X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Patients undergoing unilateral Anterior Cruciate Ligament Reconstruction (ACLR)Activity monitoring4 - 5 visits: Clinical examination, magnetic resonance imaging (MRI), 3D motion analysis, Strength assessment, EOS radiography (full leg X-ray scan), X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Patients undergoing unilateral Anterior Cruciate Ligament Reconstruction (ACLR)Questionnaires4 - 5 visits: Clinical examination, magnetic resonance imaging (MRI), 3D motion analysis, Strength assessment, EOS radiography (full leg X-ray scan), X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Healthy controls without previous Anterior Cruciate Ligament (ACL) injuryActivity monitoring2 visits: Clinical examination, MRI, 3D motion analysis, Strength assessment, EOS radiography, X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Healthy controls without previous Anterior Cruciate Ligament (ACL) injuryQuestionnaires2 visits: Clinical examination, MRI, 3D motion analysis, Strength assessment, EOS radiography, X-ray scan knee, Blood sample, Questionnaires and Activity monitoring.
Primary Outcome Measures
NameTimeMethod
Knee contact forces (KCF) will be measured using a 3D motion analysis system2 years

The goal is to profile longitudinal changes in KCFs of the articular cartilage.

Using a 3D motion analysis system (Vicon, Oxford Metrics, UK), marker trajectories, ground reaction forces (AMTI, MA, USA) and muscle activations (Wireless EMG Cometa, Italy) will be measured. Subsequently a musculoskeletal modelling workflow in OpenSim will be used to calculate Knee contact forces (KCF) of the articular cartilage.

Knee contact pressures (KCP) will be measured using a 3D motion analysis system2 years

Using a 3D motion analysis system (Vicon, Oxford Metrics, UK), marker trajectories, ground reaction forces (AMTI, MA, USA) and muscle activations (Wireless EMG Cometa, Italy) will be measured. Subsequently a musculoskeletal modelling workflow in OpenSim will be used to calculate Knee contact pressures (KCP) of the articular cartilage.

The patient-specific cartilage thickness distribution.2 years

The cartilage thickness will be measured using the semi-automatic segmentation from the high-resolution images (3D-FSE) of the tibiofemoral cartilage.

The patient-specific tibiofemoral cartilage quality.2 years

The cartilage quality will be examined using compositional measures such as T1rho, T1p and T2 relaxation time.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Faculty of Kinesiology and Rehabilitation Sciences

🇧🇪

Leuven, Vlaams-Brabant, Belgium

© Copyright 2025. All Rights Reserved by MedPath